Profile | GDS5420 / 225304_s_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 1323.49 | 83 |
GSM1296119 | B_lesional_pre-dose | 1218.85 | 82 |
GSM1296076 | C_lesional_pre-dose | 1071.7 | 80 |
GSM1296092 | D_lesional_pre-dose | 1676.62 | 86 |
GSM1296103 | E_lesional_pre-dose | 1778.35 | 87 |
GSM1296078 | F_lesional_pre-dose | 800.15 | 76 |
GSM1296107 | G_lesional_pre-dose | 1469.75 | 85 |
GSM1296109 | H_lesional_pre-dose | 1495.57 | 86 |
GSM1296080 | I_lesional_pre-dose | 681.68 | 73 |
GSM1296090 | J_lesional_pre-dose | 1591.5 | 86 |
GSM1296074 | K_lesional_pre-dose | 1106.44 | 80 |
GSM1296111 | L_lesional_pre-dose | 1158.28 | 82 |
GSM1296099 | M_lesional_pre-dose | 2024.63 | 89 |
GSM1296086 | O_lesional_pre-dose | 1373.64 | 83 |
GSM1296117 | P_lesional_pre-dose | 1593.94 | 86 |
GSM1296113 | Q_lesional_pre-dose | 1155.6 | 82 |
GSM1296096 | R_lesional_pre-dose | 2077.95 | 89 |
GSM1296105 | S_lesional_pre-dose | 1100.65 | 81 |
GSM1296098 | T_lesional_pre-dose | 1006.75 | 79 |
GSM1296101 | U_lesional_pre-dose | 1591.87 | 86 |
GSM1296121 | V_lesional_pre-dose | 1212.44 | 82 |
GSM1296088 | W_lesional_pre-dose | 1223.59 | 82 |
GSM1296082 | X_lesional_pre-dose | 1598.26 | 85 |
GSM1296115 | Y_lesional_pre-dose | 1541.8 | 86 |
GSM1296084 | Z_lesional_pre-dose | 1183.99 | 82 |
GSM1296072 | B_lesional_day8 | 928.32 | 78 |
GSM1296069 | L_lesional_day8 | 1069.78 | 81 |
GSM1296071 | P_lesional_day8 | 1111.16 | 81 |
GSM1296070 | Y_lesional_day8 | 1414.54 | 85 |
GSM1296073 | V_lesional_day8 | 1204.42 | 82 |
GSM1296034 | A_lesional_day15 | 461.69 | 65 |
GSM1296041 | G_lesional_day15 | 1531.25 | 86 |
GSM1296035 | R_lesional_day15 | 2034.6 | 89 |
GSM1296038 | U_lesional_day15 | 2113.09 | 90 |
GSM1296047 | B_lesional_day15 | 861.9 | 77 |
GSM1296039 | E_lesional_day15 | 2064.09 | 89 |
GSM1296042 | H_lesional_day15 | 1259.77 | 83 |
GSM1296043 | L_lesional_day15 | 1262.74 | 83 |
GSM1296037 | M_lesional_day15 | 2003.33 | 89 |
GSM1296046 | P_lesional_day15 | 923.71 | 78 |
GSM1296044 | Q_lesional_day15 | 1169.01 | 82 |
GSM1296045 | Y_lesional_day15 | 1295.45 | 84 |
GSM1296025 | C_lesional_day15 | 284.57 | 59 |
GSM1296033 | D_lesional_day15 | 1093.03 | 80 |
GSM1296027 | I_lesional_day15 | 595.37 | 71 |
GSM1296032 | J_lesional_day15 | 955.99 | 78 |
GSM1296024 | K_lesional_day15 | 287.93 | 59 |
GSM1296031 | W_lesional_day15 | 1166.51 | 82 |
GSM1296028 | X_lesional_day15 | 940.59 | 78 |
GSM1296029 | Z_lesional_day15 | 971.57 | 78 |
GSM1296026 | F_lesional_day15 | 665.32 | 73 |
GSM1296030 | O_lesional_day15 | 952.41 | 78 |
GSM1296040 | S_lesional_day15 | 1782.11 | 88 |
GSM1296036 | T_lesional_day15 | 1016.57 | 79 |
GSM1296048 | V_lesional_day15 | 1288.95 | 83 |
GSM1296059 | A_lesional_day43 | 2133.05 | 90 |
GSM1296066 | G_lesional_day43 | 1256.51 | 83 |
GSM1296060 | R_lesional_day43 | 1759.11 | 88 |
GSM1296063 | U_lesional_day43 | 1862.43 | 88 |
GSM1296064 | E_lesional_day43 | 1975.54 | 88 |
GSM1296067 | H_lesional_day43 | 1010.92 | 80 |
GSM1296062 | M_lesional_day43 | 1296.11 | 83 |
GSM1296068 | Q_lesional_day43 | 1148.2 | 82 |
GSM1296050 | C_lesional_day43 | 551.02 | 70 |
GSM1296057 | D_lesional_day43 | 1563.93 | 86 |
GSM1296052 | I_lesional_day43 | 560.11 | 70 |
GSM1296054 | J_lesional_day43 | 722.53 | 74 |
GSM1296049 | K_lesional_day43 | 353.04 | 62 |
GSM1296055 | W_lesional_day43 | 1649.36 | 87 |
GSM1296053 | X_lesional_day43 | 687.13 | 73 |
GSM1296058 | Z_lesional_day43 | 1309.93 | 83 |
GSM1296051 | F_lesional_day43 | 853.77 | 77 |
GSM1296056 | O_lesional_day43 | 1909.24 | 88 |
GSM1296065 | S_lesional_day43 | 1913.15 | 89 |
GSM1296061 | T_lesional_day43 | 796.72 | 75 |
GSM1296095 | A_non-lesional_pre-dose | 1984.87 | 89 |
GSM1296120 | B_non-lesional_pre-dose | 1008.95 | 79 |
GSM1296077 | C_non-lesional_pre-dose | 496.69 | 68 |
GSM1296093 | D_non-lesional_pre-dose | 759.37 | 74 |
GSM1296104 | E_non-lesional_pre-dose | 2031.75 | 89 |
GSM1296079 | F_non-lesional_pre-dose | 492.64 | 68 |
GSM1296108 | G_non-lesional_pre-dose | 1344.63 | 84 |
GSM1296110 | H_non-lesional_pre-dose | 987.71 | 79 |
GSM1296081 | I_non-lesional_pre-dose | 688.04 | 73 |
GSM1296091 | J_non-lesional_pre-dose | 1237.29 | 82 |
GSM1296075 | K_non-lesional_pre-dose | 898.71 | 77 |
GSM1296112 | L_non-lesional_pre-dose | 1156.17 | 82 |
GSM1296100 | M_non-lesional_pre-dose | 1740.71 | 88 |
GSM1296087 | O_non-lesional_pre-dose | 723.88 | 74 |
GSM1296118 | P_non-lesional_pre-dose | 1005.96 | 80 |
GSM1296114 | Q_non-lesional_pre-dose | 1017.16 | 80 |
GSM1296097 | R_non-lesional_pre-dose | 1924.62 | 89 |
GSM1296106 | S_non-lesional_pre-dose | 1339.35 | 84 |
GSM1296102 | U_non-lesional_pre-dose | 1117.39 | 81 |
GSM1296122 | V_non-lesional_pre-dose | 940.68 | 78 |
GSM1296089 | W_non-lesional_pre-dose | 1252.6 | 83 |
GSM1296083 | X_non-lesional_pre-dose | 916.05 | 78 |
GSM1296116 | Y_non-lesional_pre-dose | 998.73 | 80 |
GSM1296085 | Z_non-lesional_pre-dose | 1062.21 | 80 |